Cardiopulmonary Bypass Equipment Market Report 2018-2026 Focuses On Top Companies Medtronic Plc, LivaNova PLC, MAQUET Holding B.V. & Co. KG., Terumo Corporation, Braile Biomedica

The global cardiopulmonary bypass equipment market size was valued at US$ 111.33 million in 2017, and is expected to witness a CAGR of 1.2% over the forecast period (2018 – 2026).

Cardiopulmonary bypass equipment is a machine which takes over the function of heart and lungs to maintain the circulation of blood and the oxygen content of the patient's body during coronary bypass heart surgery. This equipment also known as heart lung machine. Cardiopulmonary bypass machine consists of two main components, the pump and the oxygenator which remove oxygen-deprived blood from a patient's body and replace it with oxygen-rich blood through a series of hoses. Surgeons are able to perform coronary artery bypass grafting (CABG), for valve repair or repair of cardiac anomalies, and aortic aneurysm repairs, along with treatment of other cardiac-related diseases.

The increase in the prevalence of cardiovascular diseases like atrial fibrillation, atrial flutter and supraventricular tachycardia, decrease in heart muscle elasticity, decrease in heart output, aging population are the driving factors for the growth of cardiopulmonary bypass equipment market

Download the PDF brochure:
https://www.coherentmarketinsights.com/insight/request-pdf/2026

For instance, According to the American Heart Association, in 2013, cardiovascular disease is the foremost global cause of deaths among the population, accounting for about 17.3 million deaths per year. According to the same report, the number of deaths is expected to rise to around 23.6 million by 2030. Increasing adoption of unhealthy dietary habits, lack of proper exercise, increasing stress, and sedentary lifestyles are increasing occurrences of heart-related diseases, especially heart failures. This in turn is increasing demand for cardiopulmonary bypass equipment, thus expected to boost market growth over the forecast period.

Increasing number of organ transplant surgeries is expected to drive growth of the market over the forecast period. For instance, according to Organ and Tissue Authority of Australian Government, the number of surgeries performed for organ transplant in 2017 were around1, 469. Moreover, around 1,400 Australians are waiting for organ transplant. However, recall of the components of cardiopulmonary bypass equipment may hinder the growth of the market during the forecast period. For instance, in October 2012, US FDA terminated the Maquet HL Console for Heart Lung Machine HL20 for its device design. As Maquet HL 20 Twin Pump Modules may unintentionally increase speeds for a 1.5-2 second period of time before returning to its original speed.

Get HOLISTIC Request Sample Copy Of This Business Report:
https://www.coherentmarketinsights.com/insight/request-sample/2026

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:
Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email:sales@coherentmarketinsights.com

This release was published on openPR.